Member Type: Personalized Medicine Service Providers
Perthera guides advanced-stage cancer patients and their physicians to the best-in-class personalized cancer treatment options available by bridging the gap between molecular testing and patient therapy.
Perthera's unique approach uses the most advanced molecular diagnostic testing to create a detailed analysis of a patient’s unique cancer. Perthera’s proprietary Expert Oncology Platform, ExpO, combines that analysis with the patient’s medical history and generates a comprehensive PrecisOn analysis. The company's dedicated medical panel reviews the analysis and makes recommendations based on the latest cancer treatment options available. Perthera is not a lab; it is an oncology solutions service empowering oncologists at the point of care with improved physician decision-making and optimized therapy options unique for each patient.